Personal profile
Clinical interests
Medical oncology, breast cancer, breast oncology
Fingerprint
Dive into the research topics where Andrew Davis is active. These topic labels come from the works of this person and are generated automatically. Together they form a unique fingerprint. Contact the Profiles team with questions.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Dual-positive CTCs in patients with advanced breast cancer show metastatic potential and prognostic value
Reduzzi, C., Nicolò, E., Gerratana, L., Ozimski, L. L., Silvestri, M., Zhang, Y., Scholten, D., Serafini, M. S., Manai, M., D’Amico, P., Molteni, E., Bayou, N., Pastò, B., Saini, M., Davis, A. A., Cosimo, S. D., Cappelletti, V., Liu, H., Gradishar, W. J. & Aceto, N. & 1 others, , Mar 11 2026, In: Science translational medicine. 18, 840, eadw7698.Research output: Contribution to journal › Article › peer-review
-
Circulating genomic landscape following cyclin-dependent kinase 4/6 inhibitors exposure in HR + /HER2− metastatic breast cancer: a retrospective multi-institutional Consortium analysis
Pontolillo, L., Davis, A. A., Gerratana, L., Medford, A. J., Wang, J., Nicolo’, E., Clifton, K., Velimirovic, M., Warrior, S., Podany, E., Andreopoulou, E., Serafini, M. S., Munoz-Arcos, L., Molteni, E., Lipsyc-Sharf, M., Gianni, C., Bayou, N., Dai, C. S., Giannarelli, D. & Bria, E. & 4 others, , Dec 2025, In: npj Breast Cancer. 11, 1, 93.Research output: Contribution to journal › Article › peer-review
Open Access -
Detection of Circulating Tumor DNA Using a Tissue-Free Epigenomic Assay Is a Highly Prognostic Biomarker in Early-Stage Triple-Negative Breast Cancer
Ademuyiwa, F. O., Ma, C. X., Weilbaecher, K., Suresh, R., Peterson, L. L., Bose, R., Bagegni, N., Rigden, C. E., Frith, A., Clifton, K., Dustin, D., Cai, M., Xiong, L., Chen, S. & Davis, A. A., Jun 1 2025, In: Clinical Cancer Research. 31, 11, p. 2173-2182 10 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Link opens in a new tab Scopus citations -
Evolving concepts in HER2-low breast cancer: Genomic insights, definitions, and treatment paradigms
Hensing, W. L., Podany, E. L., Sears, J. J., Tapiavala, S. & Davis, A. A., 2025, In: Oncotarget. 16, p. 11-27 17 p.Research output: Contribution to journal › Review article › peer-review
Open Access4 Link opens in a new tab Scopus citations -
Genomic and proteomic profiling of GATA3 mutant metastatic hormone receptor-positive breast cancer and impact on clinical outcomes
Medford, A. J., Velimirovic, M., Gefen, Y., Niemierko, A., Gerratana, L., Davis, A. A., Clifton, K., Keenan, J., Podany, E., Hensing, W. L., Reduzzi, C., Dai, C. S., Kiedrowski, L. A., Spring, L. M., Ellisen, L. W., Doebele, R. C., Cristofanilli, M., Getz, G. & Bardia, A., Aug 2025, In: Breast Cancer Research and Treatment. 212, 3, p. 437-447 11 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations